CDK6 and malignant colon neoplasm: Kawasaki et al. [30] demonstrated that MYU binds to hnRNP-K and stabilizes CDK6 expression, thereby promoting the G1–S phase transition and playing a key role in the proliferation and tumorigenicity of colon cancer cells.